Position in GRAL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$974,895
+$545,951 QoQ
Shares Held
14,280
+72.0% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#113
of 371 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Trifecta Capital Advisors, LLC holds $7,224,312 across 10 Diagnostics & Research names. GRAL ranks #2 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
12,002 | $6,017,322 | |
| 2 | GRAL |
GRAIL, Inc.
This page
|
14,280 | $974,895 | |
| 3 | NTRA |
Natera, Inc.
|
595 | $161,512 | |
| 4 | TWST |
Twist Bioscience Corp
|
610 | $62,756 | |
| 5 | WAT |
Waters Corp /De/
|
13 | $4,875 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
3 | $1,579 | |
| 7 | DHR |
Danaher Corp /De/
|
3 | $571 | |
| 8 | A |
Agilent Technologies, Inc.
|
3 | $398 |
All Filings in GRAL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $974,895 | 14,280 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $428,944 | 8,300 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,459,309 | 17,050 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,280,164 | 21,650 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $586,188 | 11,400 | Shares | Sole | 2025-07-23 | |
| No filing history on record for this holder in this stock. | ||||||